By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
Because your health doesn’t wait, and neither should your policy. Highlights: Health insurance typically comes with a waiting period before certain conditions are covered Zero waiting period means you can get coverage for select treatments ...
Read MoreGroup net sales grow by 6.3%* to EURÂ 14.0Â billion, driven by Human Pharma (EURÂ 11.3Â billion) and Animal Health (EURÂ 2.6Â billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in H2 2025 Strategic ...
Read MorePR Newswire HONG KONG, July 28, 2025 HONG KONG, July 28, 2025 /PRNewswire/ --Â Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New ...
Read MorePR Newswire HONG KONG, July 27, 2025 -     First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot ...
Read MorePR Newswire SINGAPORE and LEXINGTON, Mass., July 27, 2025 Collaboration focuses on advancing clinically validated armored CAR technologies into first-in-human trials in Singapore and accelerate translational research from bench-to-bedside ...
Read MorePR Newswire TORONTO, July 27, 2025 Key Takeaways TORONTO, July 27, 2025 /PRNewswire/ -- Historic lead levels from the era of leaded gasoline may be contributing to cognitive issues 50 years later, suggests research reported for the first ...
Read MoreBecause your health doesn’t wait, and neither should your policy. Highlights: Health insurance typically comes with a waiting period before certain conditions are covered Zero waiting period means you can get coverage for select treatments ...
Read MorePR Newswire ARLINGTON, Va., July 25, 2025 ARLINGTON, Va., July 25, 2025 /PRNewswire/ -- Yesterday, the White House released a new Executive Order, "Ending Crime and Disorder on America's Streets," which directs federal agencies to make it ...
Read MorePR Newswire CHICAGO, July 25, 2025 New Teeth Chicago Dental Implant Center and Dr. Irfan Atcha steps in to take over dental implant treatment of abandoned patients from the closed corporate dental implant centers in Chicagoland area. ...
Read MorePR Newswire BOSTON, July 25, 2025 "Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON, July ...
Read MorePR Newswire DELRAY BEACH, Fla., July 25, 2025 DELRAY BEACH, Fla., July 25, 2025 /PRNewswire/ -- The global Healthcare Analytical Testing Services Market, valued at US$6.33 billion in 2024Â stood at US$7.48 billion in 2025 and is projected to ...
Read MorePR Newswire PHILADELPHIA, July 25, 2025 A combination of interventions is optimal to prevent children from dying in overheated cars PHILADELPHIA, July 25, 2025 /PRNewswire/ -- Different technologies have been developed to help parents ...
Read MorePR Newswire WOBURN, Mass., July 25, 2025 WOBURN, Mass., July 25, 2025 /PRNewswire/ -- Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its SPEAR ...
Read MorePR Newswire CAESAREA, Israel, July 25, 2025 Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study ...
Read MorePR Newswire HUNTINGTON, N.Y., July 25, 2025 Cliantha Research spearheads clinical study as growing evidence and investor enthusiasm converge around inflammation-based innovation. HUNTINGTON, N.Y., July 25, 2025 /PRNewswire/ -- Sen-Jam ...
Read MorePR Newswire INDIANAPOLIS, July 25, 2025 INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a ...
Read MorePR Newswire SUZHOU, China, July 25, 2025 SUZHOU, China, July 25, 2025 /PRNewswire/ --Â The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed ...
Read MorePR Newswire TORONTO, July 25, 2025 Elaine Yuen Healer Inc. introduces a 13-week coaching program that helps high-achieving women over 30 build confidence, master emotional intelligence, and reconnect with their intuition to bridge the ...
Read MorePR Newswire BOSTON, July 25, 2025 BOSTON, July 25, 2025 /PRNewswire/ -- Servier today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending ...
Read MorePR Newswire PRINCETON, N.J., July 25, 2025 PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced it will ...
Read MoreCanada NewsWire TORONTO, July 25, 2025 Support local women's shelters and food banks via the Pad It Forward campaign TORONTO, July 25, 2025 /CNW/ - Shoppers Foundation for Women's Healthâ„¢ is inviting Canadians to join them in their fight ...
Read MorePR Newswire INDIANAPOLIS, July 25, 2025 The opinion will now be referred to the European Commission for final regulatory decision on donanemab INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today ...
Read MorePR Newswire LAS VEGAS, July 24, 2025 The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of rheumatoid ...
Read MorePR Newswire LAS VEGAS, July 24, 2025 The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of the B7-H4 biomarker, and ...
Read MorePR Newswire VANCOUVER, BC, July 24, 2025 The International Council on Active Aging® (ICAA) has announced a new partnership with LeadingAge to expand the reach of Active Aging Week 2025, presented by Humana. Taking place October 6–12, this ...
Read MorePR Newswire WASHINGTON, July 24, 2025 Organization to Participate in 12 National Events as Part of Innovative Health Education Initiative WASHINGTON, July 24, 2025 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung ...
Read MorePR Newswire HONG KONG, July 23, 2025 HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical ...
Read MorePR Newswire ST. LOUIS, July 23, 2025 AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST. LOUIS, July 23, 2025 /PRNewswire/ --Â Mercy's strategic and carefully planned use ...
Read MorePR Newswire GENEVA, July 24, 2025 GENEVA, July 24, 2025 /PRNewswire/ -- On International Self-Care Day, and as world leaders prepare for a landmark United Nations General Assembly meeting on non-communicable diseases (NCDs) this September, ...
Read MorePR Newswire SAN DIEGO, July 23, 2025 SAN DIEGO, July 23, 2025 /PRNewswire/ -- Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known ...
Read MoreCanada NewsWire MISSISSAUGA, ON, July 23, 2025 MISSISSAUGA, ON, July 23, 2025 /CNW/ - GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with bortezomib and dexamethasone, or in ...
Read MorePR Newswire FRANKLIN LAKES, N.J., July 23, 2025 FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ --Â BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
Read More